Last reviewed · How we verify
Placebo of DWJ1252 — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo of DWJ1252 (Placebo of DWJ1252) — Daewoong Pharmaceutical Co. LTD.. This is a placebo control and contains no active pharmaceutical ingredient.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo of DWJ1252 TARGET | Placebo of DWJ1252 | Daewoong Pharmaceutical Co. LTD. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo of DWJ1252 CI watch — RSS
- Placebo of DWJ1252 CI watch — Atom
- Placebo of DWJ1252 CI watch — JSON
- Placebo of DWJ1252 alone — RSS
Cite this brief
Drug Landscape (2026). Placebo of DWJ1252 — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-of-dwj1252. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab